ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SpyGlass Pharma Inc
26.25
+10.25
64.06%
成交量:
91.85萬
成交額:
2,365.67萬
市值:
8.38億
市盈率:
- -
高:
32.44
開:
24.00
低:
20.16
收:
16.00
52周最高:
32.44
52周最低:
20.16
股本:
3,191.12萬
流通股本:
940.00萬
量比:
- -
換手率:
9.77%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
異動解讀 | SpyGlass Pharma納斯達克IPO首日開盤價翻倍,盤中大漲50%
异动解读
·
3小時前
BUZZ-SpyGlass 在納斯達克首次公開募股 1.5 億美元后有望高開
路透中文
·
4小時前
美股異動 | SpyGlass Pharma(SGP.US)登陸美股市場 開盤暴升逾43%
智通财经
·
4小時前
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/SGP/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","market":"US","secType":"STK","nameCN":"SpyGlass Pharma Inc","latestPrice":26.25,"timestamp":1770410073231,"preClose":16,"halted":0,"volume":918529,"delay":0,"changeRate":0.640625,"floatShares":9400000,"shares":31911200,"eps":0,"marketStatus":"待開盤","change":10.25,"latestTime":"02-06 15:34:33 EST","open":24,"high":32.44,"low":20.16,"amount":23656661.120318,"amplitude":0.7675,"askPrice":27.45,"askSize":207,"bidPrice":25.5,"bidSize":354,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1770411600000},"marketStatusCode":16,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":16,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","floatShares":9400000,"roa":"--","roe":"--","lyrEps":0,"shares":31911200,"dividePrice":0,"high":32.44,"amplitude":0.7675,"preClose":16,"low":20.16,"week52Low":20.16,"pbRate":"--","week52High":32.44,"institutionHeld":0,"latestPrice":26.25,"committee":0.262032,"eps":0,"divideRate":0,"volume":918529,"delay":0,"ttmEps":0,"open":24,"prevYearClose":16,"fiveDayClose":16,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1173758808","title":"異動解讀 | SpyGlass Pharma納斯達克IPO首日開盤價翻倍,盤中大漲50%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173758808","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173758808?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 01:29","pubTimestamp":1770398971,"startTime":"0","endTime":"0","summary":"生物制药公司SpyGlass Pharma, Inc.今日盘中股价大幅上涨,涨幅达到50.00%,引起了市场的广泛关注。消息面上,SpyGlass Pharma今日在纳斯达克成功完成首次公开募股,开盘价达到每股32美元,远高于其16美元的发行价。此次IPO以每股15至17美元的价格区间出售了约940万股股票,共融资1.5亿美元。SpyGlass Pharma成立于2019年,专注于为慢性眼病开发长效疗法的药物输送系统。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SGP"],"gpt_icon":0},{"id":"2609898590","title":"BUZZ-SpyGlass 在納斯達克首次公開募股 1.5 億美元后有望高開","url":"https://stock-news.laohu8.com/highlight/detail?id=2609898590","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609898590?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 00:00","pubTimestamp":1770393659,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4T3Z21PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","LU0162691827.USD","LU0098860793.USD","LU2417539215.USD","BK4588","LU0072461881.USD","BK4566","LU1506573853.SGD","LU1267930227.SGD","BK4534","BK4559","LU0648001328.SGD","LU0314106906.USD","LU0052756011.USD","LU1244550494.USD","LU1791807156.HKD","LU1366192091.USD","LU0130102774.USD","LU1162221912.USD","LU1668664300.SGD","LU0980610538.SGD","LU1244550577.SGD","LU0130517989.USD","LU2462157665.USD","SGP","BK4127","LU0128525689.USD","SF","LU2125154778.USD","BK4207","IE00BSNM7G36.USD","LU0170899867.USD","LU1201861249.SGD","LU0310800965.SGD","LU2456880835.USD","LU0477156953.USD","LU2125154935.USD","LU0320765646.SGD","BK4585","LU2360032135.SGD","MNSH","BK4504","LU2236285917.USD","LU1244550221.USD"],"gpt_icon":0},{"id":"2609839513","title":"美股異動 | SpyGlass Pharma(SGP.US)登陸美股市場 開盤暴升逾43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609839513","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609839513?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 00:00","pubTimestamp":1770393633,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周五,SpyGlass Pharma(SGP.US)登陆美股市场,开盘股价暴涨超43%,报23美元,IPO价格为16美元。SpyGlass Pharma 是一家临床后期生物技术公司,专注于开发 用于慢性眼部疾病的持续药物输送系统,旨在通过更长效、可持续的治疗方案改善患者的视力和生活质量。其核心研发产品包括一种将药物输送垫与人工晶状体结合的系统,用于治疗像 开角型青光眼或眼压高 等慢性眼病。这类治疗目标是提高疗效和患者依从性,与传统每日滴眼药水相比有潜在优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4535","BK4550","MNQmain","TWM","BK4585","RWM","BK4581","SGP","BK4534","IWO","SRTY","BK4588","UWM","TZA","TNA","IWN"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}